TARGET BP I Clinical Trial (TARGET BP I)
What is the purpose of this trial?
The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization
- Ages18 years - 80 years
- Trial withAblative Solutions, Inc.
- Start Date10/30/2019
- End Date12/30/2021
- Last Updated05/04/2021
- Study HIC#2000025879